newsfilter
← Latest News
GlobeNewswire·

UroGen Pharma to Present at Upcoming Investor Conferences

PRINCETON, N.J., Sept. 02, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers,